Your session is about to expire
← Back to Search
Guselkumab for Ulcerative Colitis (ASTRO Trial)
ASTRO Trial Summary
This trial will test if the drug guselkumab is effective in treating ulcerative colitis.
ASTRO Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowASTRO Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 2 trial • 214 Patients • NCT03662542ASTRO Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I currently have a severe case of COVID-19.My condition did not improve with standard treatments.My ulcerative colitis affects only my rectum.I haven't had surgery in the last 8 weeks and don't plan to during the study.I am 18 years old or older.My ulcerative colitis is moderate to severe according to the Mayo score.I was diagnosed with ulcerative colitis more than 12 weeks ago.I have been diagnosed with a specific type of colitis or Crohn's disease.My condition did not improve with standard treatments.My ulcerative colitis is moderate to severe according to the Mayo score.
- Group 1: Group 2: Guselkumab
- Group 2: Group 1: Guselkumab
- Group 3: Group 3: Placebo
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many different hospitals or care centers are participating in this research?
"Currently, this research is being conducted at 25 different locations. These include sites in Lake Success, Westlake and Chesterfield as well as other cities. If you choose to participate in this study, it would be best to select the location nearest you to minimize travel demands."
Are there any spots available for volunteers in this research?
"Yes, this trial is currently open for enrollment. According to the information on clinicaltrials.gov, the study was posted on September 13th, 2020 and updated November 2nd, 2020."
What are the risks associated with Guselkumab Dose 1?
"There is some evidence that Guselkumab Dose 1 is effective, and it has been through multiple safety trials, so it received a score of 3."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- Emory University: < 24 hours
Average response time
- < 1 Day
Share this study with friends
Copy Link
Messenger